Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Bradykinin B2 | 4 | 2013 | 12 | 1.440 |
Why?
|
| Neurons | 7 | 2015 | 1175 | 1.050 |
Why?
|
| Neuroprotective Agents | 5 | 2015 | 245 | 1.040 |
Why?
|
| Bradykinin | 3 | 2013 | 22 | 0.790 |
Why?
|
| Diterpenes | 3 | 2015 | 92 | 0.690 |
Why?
|
| Cell Differentiation | 5 | 2015 | 587 | 0.650 |
Why?
|
| Isoflurophate | 2 | 2014 | 10 | 0.570 |
Why?
|
| Acetylcholinesterase | 3 | 2015 | 55 | 0.560 |
Why?
|
| Pyridostigmine Bromide | 1 | 2015 | 5 | 0.520 |
Why?
|
| Receptor, Bradykinin B1 | 2 | 2012 | 5 | 0.510 |
Why?
|
| Brain Ischemia | 1 | 2015 | 184 | 0.430 |
Why?
|
| N-Methylaspartate | 1 | 2012 | 57 | 0.410 |
Why?
|
| Cell Survival | 1 | 2015 | 864 | 0.400 |
Why?
|
| Stroke | 1 | 2015 | 286 | 0.390 |
Why?
|
| Brain | 2 | 2015 | 1346 | 0.360 |
Why?
|
| SELEX Aptamer Technique | 2 | 2006 | 5 | 0.350 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2015 | 43 | 0.340 |
Why?
|
| Aptamers, Nucleotide | 2 | 2006 | 31 | 0.290 |
Why?
|
| Animals | 15 | 2015 | 15081 | 0.250 |
Why?
|
| Rats | 8 | 2015 | 3483 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2015 | 1618 | 0.230 |
Why?
|
| Paraoxon | 2 | 2015 | 9 | 0.230 |
Why?
|
| Cells, Cultured | 4 | 2015 | 1518 | 0.190 |
Why?
|
| Neuroglia | 2 | 2015 | 124 | 0.180 |
Why?
|
| RNA | 3 | 2006 | 241 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 2231 | 0.170 |
Why?
|
| Hippocampus | 2 | 2013 | 561 | 0.160 |
Why?
|
| DNA | 3 | 2006 | 574 | 0.160 |
Why?
|
| Cell Line | 2 | 2015 | 1354 | 0.160 |
Why?
|
| Stem Cells | 2 | 2009 | 141 | 0.150 |
Why?
|
| Receptors, Nicotinic | 2 | 2010 | 106 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2014 | 34 | 0.130 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2015 | 14 | 0.130 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 20 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 58 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 133 | 0.120 |
Why?
|
| Glucose | 1 | 2015 | 230 | 0.110 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 103 | 0.110 |
Why?
|
| Mice | 4 | 2015 | 5913 | 0.110 |
Why?
|
| Astrocytes | 1 | 2015 | 255 | 0.110 |
Why?
|
| Carboxypeptidases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2014 | 121 | 0.100 |
Why?
|
| Kallikreins | 2 | 2009 | 9 | 0.100 |
Why?
|
| Brain Chemistry | 1 | 2012 | 140 | 0.100 |
Why?
|
| Action Potentials | 1 | 2013 | 231 | 0.100 |
Why?
|
| Male | 5 | 2015 | 20025 | 0.100 |
Why?
|
| Pheochromocytoma | 1 | 2010 | 11 | 0.090 |
Why?
|
| Myelopoiesis | 1 | 2010 | 2 | 0.090 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2010 | 31 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1371 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2010 | 102 | 0.090 |
Why?
|
| Carbachol | 2 | 2005 | 19 | 0.080 |
Why?
|
| Carcinoma, Embryonal | 1 | 2008 | 2 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 71 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 286 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2009 | 135 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2008 | 233 | 0.080 |
Why?
|
| Suramin | 1 | 2006 | 4 | 0.070 |
Why?
|
| Drug Stability | 1 | 2006 | 116 | 0.070 |
Why?
|
| Oligoribonucleotides | 1 | 2005 | 4 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 52 | 0.060 |
Why?
|
| Kininogens | 1 | 2005 | 4 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 18 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 196 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 191 | 0.060 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2004 | 11 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 677 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2005 | 101 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2005 | 128 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 435 | 0.050 |
Why?
|
| Base Sequence | 1 | 2005 | 997 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 360 | 0.050 |
Why?
|
| Peptides | 1 | 2005 | 320 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 674 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 369 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1207 | 0.050 |
Why?
|
| PC12 Cells | 2 | 2010 | 93 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2006 | 136 | 0.030 |
Why?
|
| Female | 1 | 2015 | 20969 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2006 | 111 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 77 | 0.030 |
Why?
|
| Seizures | 1 | 2014 | 68 | 0.030 |
Why?
|
| Humans | 5 | 2015 | 37093 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 267 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 381 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 513 | 0.030 |
Why?
|
| Cholinesterase Reactivators | 1 | 2011 | 4 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 2011 | 6 | 0.020 |
Why?
|
| Pralidoxime Compounds | 1 | 2011 | 5 | 0.020 |
Why?
|
| Atropine | 1 | 2011 | 13 | 0.020 |
Why?
|
| Kallikrein-Kinin System | 1 | 2010 | 1 | 0.020 |
Why?
|
| Captopril | 1 | 2010 | 8 | 0.020 |
Why?
|
| Granulocytes | 1 | 2010 | 29 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 36 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 81 | 0.020 |
Why?
|
| Kinins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 4 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2009 | 28 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 31 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 63 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 220 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1039 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 933 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 439 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2005 | 7 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2005 | 30 | 0.020 |
Why?
|
| Gene Library | 1 | 2005 | 57 | 0.020 |
Why?
|
| Peptide Library | 1 | 2005 | 25 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1609 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2005 | 265 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 523 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 515 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 408 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 708 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 349 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 399 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1180 | 0.010 |
Why?
|
| Proteomics | 1 | 2004 | 325 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 808 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 905 | 0.010 |
Why?
|